[NBIX] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
31-Oct-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -12.98%
YoY- 21.31%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 590,200 515,300 515,200 498,800 452,700 420,400 412,000 27.10%
PBT 98,600 34,500 198,200 115,600 121,600 -103,300 117,900 -11.24%
Tax 33,600 -8,900 50,500 32,500 26,100 -26,700 28,900 10.57%
NP 65,000 43,400 147,700 83,100 95,500 -76,600 89,000 -18.91%
Tax Rate -34.08% 25.80% -25.48% -28.11% -21.46% - -24.51% -
Total Cost 525,200 471,900 367,500 415,700 357,200 497,000 323,000 38.31%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 11.01 8.42 28.67 16.66 21.10 -18.22 21.60 -36.21%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS 0.64 0.43 1.50 0.85 0.98 -0.79 0.92 -21.50%
EPS Diluted 0.63 0.42 1.44 0.82 0.95 -0.79 0.88 -19.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.